Source:http://linkedlifedata.com/resource/pubmed/id/11034269
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-1-17
|
pubmed:abstractText |
A comparison was made between methods for determining ifosfamide (IF), 2- (2DCE) and 3-dechloroethylifosfamide (3DCE) using gas chromatography with nitrogen-phosphorus detection (GC-NPD) versus positive ion electron-impact ion-trap mass spectrometry (GC-MS2). Sample pretreatment involved liquid-liquid extraction with ethyl acetate after adding trofosfamide as internal standard and alkalinization. The GC-NPD was linear, specific, and sensitive for all analytes in the range of 0.0500-100 microg/mL with lower limits of quantification (LLQ) of 0.0500 microg/mL using a 50-microgL plasma sample. The GC-MS2 was linear, specific, and sensitive for IF, 2DCE, and 3DCE in the ranges of 0.250-100, 0.500-25.0, and 0.500-25.0 microg/mL, respectively, with LLQs of 0.250, 0.500, and 0.500 microg/mL. The ranges of accuracy, within-day precision, and between-day precision for analysis of all compounds with GC-NPD did not exceed 93.3% to 105.4%, 8.0% and 9.8%, respectively. The ranges of accuracy, within-day precision, and between-day precision for analysis of all compounds with GC-MS2 did not exceed 86.5% to 99.0%, 9.0% and 12.7%, respectively. In conclusion, GC-NPD proved to be superior to GC-MS2 in sensitivity, detection range, accuracy, and precisions. Therefore GC-NPD is the method of choice for fast un-derivatized determination of IF, 2DCE, and 3DCE in human plasma, and it can readily be used for clinical pharmacokinetic studies and routine monitoring of IF-treated patients in a hospital setting.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide,
http://linkedlifedata.com/resource/pubmed/chemical/dechloroethylcyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/dechloroethylifosfamide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0163-4356
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
613-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11034269-Antineoplastic Agents, Alkylating,
pubmed-meshheading:11034269-Chromatography, Gas,
pubmed-meshheading:11034269-Cyclophosphamide,
pubmed-meshheading:11034269-Drug Monitoring,
pubmed-meshheading:11034269-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:11034269-Humans,
pubmed-meshheading:11034269-Ifosfamide,
pubmed-meshheading:11034269-Quality Control,
pubmed-meshheading:11034269-Sensitivity and Specificity
|
pubmed:year |
2000
|
pubmed:articleTitle |
Determination of ifosfamide, 2- and 3-dechloroethyifosfamide using gas chromatography with nitrogen-phosphorus or mass spectrometry detection.
|
pubmed:affiliation |
Department of Pharmacy, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|